Ascendis Pharma A/S Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2019-12-12: Form 6-K; Period of report 2019-12-12; Description 6-K; Document d844470d6k.htm.
- 2019-11-18: Form 6-K; Period of report 2019-11-18; Description 6-K; Document d834167d6k.htm.
- 2019-11-15: Form 6-K; Period of report 2019-11-15; Description 6-K; Document d821602d6k.htm.
- 2019-11-14: Form 6-K; Period of report 2019-11-14; Description 6-K; Document d825538d6k.htm.